EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Docosahexaenoic Acid Supplementation During Pregnancy and Lactation and Infant Morbidity: Findings from DHANI Trial

Shweta Khandelwal, Tavleen Kaur, Dimple Kondal, Kamal Patil, M K Swamy, D Prabhakaran, Nikhil Tandon, Usha Ramakrishnan, Aryeh D Stein

Indian Pediatrics · 2025

DOI: 10.1007/s13312-025-00007-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Pediatrics, 2025. Verfasst von Shweta Khandelwal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Chronic Disease Control, C-1/52, 2nd Floor, Safdarjung Development Area, New Delhi, 110016, India. shweta@ccdcindia.org. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Dietary Supplements, Lactation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the impact of maternal supplementation with docosahexaenoic acid (DHA) during pregnancy and lactation on the immune and inflammatory functions in infants and specific infant morbidities. METHODS: A double-blinded, parallel-group, randomized, placebo-controlled trial was conducted among healthy pregnant women aged 18-35 years, from ≤ 20 weeks gestation through 6 months postpartum, to investigate the effectiveness of supplementation of 400 mg algal-derived DHA compared to placebo. Of 3379 women who were screened, 1171 were eligible, and 957 were randomized. Occurrences of 11 common morbidity symptoms including cough, nasal congestion, difficulty in breathing, cyanosis, convulsions, fever, vomiting, rash, ear discharge, excessive crying, and diarrhea were assessed for the offspring at 1, 6, and 12 months via maternal recall. RESULTS: Overall, there were 902 (out of 957) live births. Morbidity data were available for 871, 847, and 878 infants at 1, 6 and 12 months, respectively. The history of cough, difficulty in breathing, cyanosis, convulsions, fever, and vomiting at 1, 6, or 12 months were similar across DHA and placebo groups. At 1-month of age, fewer infants in the DHA group experienced any respiratory infection symptoms (cough, nasal congestion, and/or difficulty in breathing) as compared to placebo [29.3% vs 34.9%, P = 0.04; OR (95% CI) 0.74 (0.55, 0.98)]. At 6 months, there were fewer occurrences of 'other' symptoms like anemia, constipation, conjunctivitis, jaundice, and urinary tract infections in the DHA group [1.4% vs 4.8%, P = 0.005; OR (95% CI) 0.29 (0.11, 0.72)]. CONCLUSIONS: Pre- and postnatal maternal DHA supplementation did not show major differences in the incidence of common morbidity symptoms among infants at 1, 6, and 12 months. Meticulously planned and implemented studies on morbidity during infancy will be required to assess impact of maternal DHA supplementation on the morbidity during infancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsDietary SupplementsLactationHumansFemalePregnancyDouble-Blind MethodInfantAdultYoung AdultAdolescentInfant, NewbornMorbidity

Stichwörter der Autor:innen

DHA SupplementationPregnancyRandomized controlled trialRespiratory infections

Substanzen

Docosahexaenoic Acids

Autor:innen und Institutionen

  • Centre for Chronic Disease Control, C-1/52, 2nd Floor, Safdarjung Development Area, New Delhi, 110016, India. shweta@ccdcindia.org.
  • Centre for Chronic Disease Control, C-1/52, 2nd Floor, Safdarjung Development Area, New Delhi, 110016, India.
  • KAHER's JN Medical College, JNMC KLE University Campus, Belgaum, Karnataka, India.
  • All India Institute of Medical Sciences, New Delhi, India.
  • Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, USA.

Zitieren

APA

Khandelwal, S., Kaur, T., Kondal, D., Patil, K., Swamy, M. K., Prabhakaran, D., Tandon, N., Ramakrishnan, U., & Stein, A. D. (2025). Docosahexaenoic Acid Supplementation During Pregnancy and Lactation and Infant Morbidity: Findings from DHANI Trial. Indian Pediatrics. https://doi.org/10.1007/s13312-025-00007-7

Vancouver

Khandelwal S, Kaur T, Kondal D, Patil K, Swamy MK, Prabhakaran D, et al. Docosahexaenoic Acid Supplementation During Pregnancy and Lactation and Infant Morbidity: Findings from DHANI Trial. Indian Pediatrics. 2025. doi:10.1007/s13312-025-00007-7

BibTeX
@article{Khandelwal2025,
  author = {Khandelwal, Shweta and Kaur, Tavleen and Kondal, Dimple and Patil, Kamal and Swamy, M K and Prabhakaran, D and Tandon, Nikhil and Ramakrishnan, Usha and Stein, Aryeh D},
  title = {Docosahexaenoic Acid Supplementation During Pregnancy and Lactation and Infant Morbidity: Findings from DHANI Trial},
  journal = {Indian Pediatrics},
  year = {2025},
  doi = {10.1007/s13312-025-00007-7}
}
Kostenlos starten →